Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1980 1
1983 1
1988 1
1989 1
1992 1
1993 1
1994 1
1995 1
1996 3
1997 5
1999 2
2000 3
2001 2
2002 6
2003 4
2004 2
2005 4
2006 7
2007 3
2008 6
2009 4
2010 5
2011 2
2012 5
2013 6
2014 3
2015 6
2016 6
2017 10
2018 9
2019 10
2020 10
2021 10
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Among authors: sinigaglia l. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
How advances in personalized medicine will change rheumatology.
Selmi C, Kon E, De Santis M, Favalli EG, Cimaz R, Generali E, Sinigaglia L. Selmi C, et al. Among authors: sinigaglia l. Per Med. 2018 Mar;15(2):75-78. doi: 10.2217/pme-2017-0079. Epub 2018 Feb 2. Per Med. 2018. PMID: 29714121 No abstract available.
Bone involvement in osteoarthritis.
Sinigaglia L, Varenna M, Casari S. Sinigaglia L, et al. Semin Arthritis Rheum. 2005 Jun;34(6 Suppl 2):44-6. doi: 10.1016/j.semarthrit.2004.03.013. Semin Arthritis Rheum. 2005. PMID: 16206957 Review. No abstract available.
Bone involvement in exogenous hypercortisolism.
Sinigaglia L, Mazzocchi D, Varenna M. Sinigaglia L, et al. J Endocrinol Invest. 2008 Apr;31(4):364-70. doi: 10.1007/BF03346372. J Endocrinol Invest. 2008. PMID: 18475057 Review.
Bone and TNF in rheumatoid arthritis: clinical implications.
Manara M, Sinigaglia L. Manara M, et al. Among authors: sinigaglia l. RMD Open. 2015 Aug 15;1(Suppl 1):e000065. doi: 10.1136/rmdopen-2015-000065. eCollection 2015. RMD Open. 2015. PMID: 26557382 Free PMC article. Review.
Epidemiology of osteoporosis in rheumatic diseases.
Sinigaglia L, Varenna M, Girasole G, Bianchi G. Sinigaglia L, et al. Rheum Dis Clin North Am. 2006 Nov;32(4):631-58. doi: 10.1016/j.rdc.2006.07.002. Rheum Dis Clin North Am. 2006. PMID: 17288969 Review.
134 results